Business Wire

The Trust Gap: Companies value digital trust but little progress is being made to implement it

29.5.2024 17:46:00 EEST | Business Wire | Press release

Share

As organisations purse digital transformation, they urgently need to prioritise digital trust to achieve their goals and prepare for future market opportunities, legislation, and regulatory compliance. New research from ISACA, the leading global professional association helping individuals and organisations in their pursuit of digital trust, reveals critical gaps in organisational strategies regarding digital trust.

The ISACA State of Digital Trust 2024 report finds that 77% of respondents agree that digital trust is crucial to digital transformation and 82% say digital trust will grow in importance over the next five years. Despite this recognition, almost three quarters (71%) report that their organisation provides no staff training on digital trust and only 21% of organizations are planning to increase their budget for digital trust.

Most (76%) business and IT professionals believe digital trust is relevant to their organisation and 65% say it is important that organisations be independently graded on digital trust practices, with the results made publicly available. ISACA defines digital trust as the confidence in the integrity of the relationships and transactions between providers and consumers within a digital ecosystem and is a key indicator of an organisation’s security credentials.

Despite recognising its relevance and importance, three quarters (75%) of respondents are either unsure or not fully aware of what improving digital trust requires in practice. A similar number (77%) report that their organisations do not currently measure the maturity of their digital trust practices or are unsure if they do.

Chris Dimitriadis, Chief Global Strategy Officer at ISACA, said: “It’s encouraging that businesses continue to recognise the importance of digital trust, not just for business sustainability, security, and profitability, but for building long-term consumer trust. Yet more needs to be done to truly achieve high levels of digital trust, which starts with measuring current levels to establish a benchmark and create a maturity plan.”

39% of organisations admit they are experiencing more cyberattacks, and 15% are suffering from more privacy breaches compared to a year ago. And this is only going to get worse if businesses don’t prioritise digital trust. Respondents recognise that organisations with low digital trust are more likely to see a reputation decline (64%), suffer from more cybersecurity incidents (58%), experience more privacy breaches (57%) and even lose customers (54%). The survey reveals that the biggest obstacles to achieving high levels of digital trust include a lack of staff skills and training (50%), lack of buy-in from leadership (42%), and insufficient processes and governance practices (32%).

Dimitriadis adds: “It is not down to business leaders alone to lead the charge - digital trust practices should be implemented and aligned across all departments to truly succeed. Our survey has found that many businesses are unsure on what improving digital trust requires in practice, but working with a trusted partner who can provide a step-by-step framework and assist in digital trust training can set the business on the right path to success and security.”

Leveraging Tools and Frameworks to Advance Trust

According to the survey, only 15 percent of respondents’ organizations currently use a framework for their digital trust practices, but almost half (46 %) of respondents believe it is extremely/very important for an organisation to have a digital trust framework. ISACA recently launched its Digital Trust Ecosystem Framework (DTEF), a comprehensive digital trust resource with indicators and controls that can be used and customised for the needs of all organisations. The DTEF roadmap and implementation guides provide a clear understanding of how organisations can attain the level of digital trust that fits their business models, strategies, and goals.

The top three benefits of using a framework include saving time and effort, enabling benchmarking with other organisations in a cost-efficient way, and providing added credibility and third-party validation in support of budget and staff requests.

Notes to Editors

All figures are based on fieldwork conducted by ISACA between 12th and 30th January 2024, amongst a total of 1,161 business and IT professionals in Europe. In total, ISACA surveyed 5,870 business and IT professionals worldwide.

About ISACA

ISACA® (www.isaca.org) is a global community advancing individuals and organizations in their pursuit of digital trust. For more than 50 years, ISACA has equipped individuals and enterprises with the knowledge, credentials, education, training and community to progress their careers, transform their organizations, and build a more trusted and ethical digital world. ISACA is a global professional association and learning organization that leverages the expertise of its 180,000 members who work in digital trust fields such as information security, governance, assurance, risk, privacy and quality. It has a presence in 188 countries, including 225 chapters worldwide. Through the ISACA Foundation, ISACA supports IT education and career pathways for underresourced and underrepresented populations.

Twitter: www.twitter.com/ISACANews
LinkedIn: www.linkedin.com/company/isaca
Facebook: www.facebook.com/ISACAGlobal
Instagram: www.instagram.com/isacanews

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Firstlight Group
+44 7960 079 643, isacateam@firstlightgroup.io

ISACA
Esther Almendros, +34 692 669 772, ealmendros@isaca.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release

International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye